Journal Guide

In the past decade research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as ‘cosmeceuticals’ in the United States, ‘quasi-drugs’ in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. Dermatologists, pharmaceutical chemists, pharmacologists, toxicologists, and others interested in the subject are invited to contribute to this exciting project and to submit their best research work for publication.

Steroids is an international journal devoted to original research on all aspects of steroids. Its focus is on both experimental and theoretical studies in chemistry and physiochemistry, biosynthesis, metabolism, molecular biology, physiology, pharmacology, analytical techniques, comparative endocrinology, clinical research, mode of action (including that of related peptides), and the role of steroids on growth and differentiation.Please bookmark this URL: http://www.elsevier.com/locate/steroidsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

For more than 50 years, clinical pharmacologists, clinical and pharmaceutical researchers, drug development specialists, physicians, nurses, and other medical professionals have relied on The Journal of Clinical Pharmacology (JCP) for original research, special reviews, commentaries, and case reports on all phases of drug development from absorption, disposition, metabolism, excretion interactions, and preferred uses through post-marketing evaluations.

A leading research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.

Therapeutic Advances in Neurological Disorders is aimed at clinicians and researchers in neurology and is a forum for presenting the latest research and reviews in this discipline, concentrating on the more-common non-cerebrovascular neurological disorders. Topics covered include: neuroimmunology; movement and neurodegenerative disorders; pain and headache; behavioral cognitive syndromes; infections and neoplasms; demyelinating diseases such as multiple sclerosis; disorders and injuries to the brain and spinal cord; epilepsy/seizure disorders.

Therapeutic Drug Monitoring is an outstanding journal that fosters the exchange of knowledge among the various disciplines--clinical pharmacology, pathology, toxicology, analytical chemistry--that share a common interest in therapeutic drug monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs; original articles; case reports; technical notes; and continuing education articles.Published BiMonthlyWebsite: www.drug-monitoring.com.

Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.TAAP also issues a standing call for outstanding Invited Review Articles. Potential authors should contact the Editor-In-Chief and complete an Invited Review Proposal Form before preparing or submitting their Review Article.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

For more information, go to http://www.cell.com/trends/pharmacological-sciences

Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds

Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English.The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Xenobiotica covers six main areas, including: General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymes Clinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in man Animal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animals Pharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobiotics Molecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular level Topics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology. A close liaison between Xenobiotica and the International Society for the Study of Xenobiotics has been established, giving rise to special issues of the journal. Read More: http://informahealthcare.com/page/xen/Description.

npj Vaccines is an online-only, open access, multidisciplinary journal that is dedicated to publishing the finest and most high-quality research and development on human and veterinary vaccines. Given the public health importance of vaccines, in addition to publishing high-quality original research, npj Vaccines also publishes commentaries, News and Views, research highlights, editorials, and correspondence from readers, to provide state-of-the-art information for those interested in vaccines. The journal is part of the Nature Partner Journals series, and is published in partnership with the Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston.